2-(4-Ethylcyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

6-[4-(3-Chlorophenyl)piperazin-1-yl]-3-cyclohexyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 98.0%, 100mg

3-tert-Butyl-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 50g

5-Fluoro-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 250mg

Boîte de protection SEKUROKA® blanc, 460 x 260 x 20 mm, 1 pièce

5,6,7,8-Tetrahydro-2-naphthalenylboronic acid, 98%, 5g

1-(5-Bromofuran-2-yl)ethan-1-one, 95+%, 100mg

2-Chloro-5-fluorophenylisothiocyanate, 97.0%, 1g

2-Methyl-2-oxazoline>98.0%(GC)100g

9,10-dichloroanthracene, 95.0%, 25g

(2-Bromo-1-fluoroethyl)benzene, 95.0%, 1g

3-(METHOXYMETHOXY)PROPANENITRILE, 95.0%, 5g

Piperazine-N,N-bis(2-ethanesulfonic acid), 99.0%, 1kg